Clinical Trial Update: Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluating meloxicam (Mobicox) to reduce prostate swelling during permanent seed brachytherapy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Mobicox (meloxicam)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostatic Neoplasms | Phase 3 | Status: COMPLETED